GlassScriptPhysician profile
Anel Monrose
NPI 1548702574
$387.14
in general payments reported to CMS, 2019-2025
11 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.28 · 2023: $145 · 2024: $122 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $132.75 | 2023-2024 | Watchman Flx |
| Intuitive Surgical, INC. | $59.77 | 2024 | |
| Novartis Pharmaceuticals Corporation | $39.16 | 2022-2023 | |
| Janssen Biotech, INC. | $31.46 | 2025 | Carvykti, Rybrevant |
| Amgen INC. | $24.27 | 2024 | Otezla |
| Cranial Technologies, INC | $20.00 | 2025 | Doc Band |
| Phadia US INC. | $19.93 | 2025 | Immunocap |
| Exeltis, USA INC. | $16.18 | 2024 | Slynd |
| Astellas Pharma US INC | $14.99 | 2023 | Veozah |
| Lilly USA, LLC | $14.36 | 2025 | Zepbound, Mounjaro |
| Shield Therapeutics INC | $14.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anel Monrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.